Insights Home Insights Featured Content Blog Automotive Litigation Trends – What Lawyers Want to Know As part of WIT’s continued commitment to staying ahead of the curve when it comes to litigation trends in evolving areas of technology, we set out to uncover which original equipment suppliers (OEMs), geographic regions, law firms, and attorneys have been shaping the automotive legal landscape and driving litigation in the space. Case Study- Life Sciences Case Study: Pharmaceutical Formulation Expert Needed for Breach of Contract and Trade Secret Litigation A pharmaceutical developer filed suit against a CDMO, alleging breach of contract and trade secret misappropriation related to a sterile injectable chemotherapy formulation. WIT provided a pharmaceutical formulation expert with deep experience in injectable drugs and scale-up processes to assess whether the data shared under the agreement was sufficient for product replication. Q&As Expert Witness Anxiety and Authenticity: A Q&A with DOAR Trial Consultant Dr. Roy Futterman How can expert witnesses connect with skeptical jurors? We asked a seasoned trial consultant from DOAR to provide strategies to help experts build credibility, manage stress, and deliver compelling testimony at trial. Blog Insights on ITC Investigation Activity, ALJ Johnson-Hines, and More from ACI’s ITC Conference This year’s ACI ITC Litigation and Enforcement Conference did not disappoint, delivering keynotes and panels on critical issues impacting the ITC. WIT was proud to sponsor the event once again and is pleased to share a few key takeaways. Case Study- Technology Case Study: Wireless Communications Expert Needed for PTAB Proceedings A technology company petitioned for IPR proceedings to challenge the validity of two wireless communications patents, arguing that the patented methods were already established industry practices. Insights & News All Focus Areas Automotive Cryptocurrency Financial Technology Former FDA Gaming Hatch-Waxman Litigation Healthcare Technology & Medical Devices ITC Investigations Pharmaceutical Wireless Communications All Insight Types Archive Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Q&As Report Video Search April 11, 2025 — Q&As Expert Witness Anxiety and Authenticity: A Q&A with DOAR Trial Consultant Dr. Roy Futterman How can expert witnesses connect with skeptical jurors? We asked a seasoned trial consultant from DOAR to provide strategies to help experts build credibility, manage stress, and deliver compelling testimony at trial. April 11, 2025 — Case Study- Life Sciences Case Study: Pharmaceutical Formulation Expert Needed for Breach of Contract and Trade Secret Litigation A pharmaceutical developer filed suit against a CDMO, alleging breach of contract and trade secret misappropriation related to a sterile injectable chemotherapy formulation. WIT provided a pharmaceutical formulation expert with deep experience in injectable drugs and scale-up processes to assess whether the data shared under the agreement was sufficient for product replication. February 18, 2025 — Q&As Rethinking Experience: Why New Expert Witnesses Deserve a Closer Look To explore the value of emerging testifying experts, we spoke with several members of the WIT team to gain insights on addressing client concerns, shifting perceptions, and how strategic preparation can turn fresh talent into indispensable litigation assets. February 3, 2025 — Press Release WIT Legal Releases 2nd Annual Report on Trends in Hatch-Waxman Litigation The new report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue throughout 2024. January 31, 2025 — Report 2024 in Review: Analyzing Hatch-Waxman Litigation Trends Our latest Hatch-Waxman report, 2024 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2024’s activities and trends in ANDA litigation. January 13, 2025 — Q&As A Conversation with WIT’s Hatch-Waxman Practice Chair: Examining 2024 ANDA Litigation Activity Recently, we spoke to our Hatch-Waxman Practice Chair, Michael Crowe, to gain insights into Hatch-Waxman litigation trends in 2024. Here’s what he had to say about filings and possible trends in the year ahead. December 18, 2024 — Report WIT Hatch-Waxman Report: Judge Michael Shipp Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp's activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings. December 12, 2024 — Blog Expert Qualifications Under Revised FRE 702: A Look at Recent Cases The 2023 amendment to Federal Rule of Evidence (FRE) 702 has introduced stricter standards for expert testimony, challenging litigators to adapt to the evolving requirements. Let’s take a look at five recent cases to see how courts are putting these requirements into practice—insights that will prove particularly valuable for litigators planning their expert strategy. December 4, 2024 — Case Study- Life Sciences Case Study: Medical Device Expert Needed for Cardiovascular Patent Dispute Before the PTAB The petitioner challenged the validity of several patents covering catheter-based delivery systems for heart valve replacement. The patent owner turned to WIT for an expert in cardiovascular medical devices and regulatory processes. November 6, 2024 — Blog Perspectives on the Amendment to Rule 702 To better understand how the amendment is reshaping the way expert testimony is being handled, we contacted key stakeholders for their insights. From the perspectives of an attorney, expert liaison, and expert witness, these changes are prompting more thorough vetting and strategic planning in selecting experts for matters. Load More Loading...
Blog Automotive Litigation Trends – What Lawyers Want to Know As part of WIT’s continued commitment to staying ahead of the curve when it comes to litigation trends in evolving areas of technology, we set out to uncover which original equipment suppliers (OEMs), geographic regions, law firms, and attorneys have been shaping the automotive legal landscape and driving litigation in the space.
Case Study- Life Sciences Case Study: Pharmaceutical Formulation Expert Needed for Breach of Contract and Trade Secret Litigation A pharmaceutical developer filed suit against a CDMO, alleging breach of contract and trade secret misappropriation related to a sterile injectable chemotherapy formulation. WIT provided a pharmaceutical formulation expert with deep experience in injectable drugs and scale-up processes to assess whether the data shared under the agreement was sufficient for product replication.
Q&As Expert Witness Anxiety and Authenticity: A Q&A with DOAR Trial Consultant Dr. Roy Futterman How can expert witnesses connect with skeptical jurors? We asked a seasoned trial consultant from DOAR to provide strategies to help experts build credibility, manage stress, and deliver compelling testimony at trial.
Blog Insights on ITC Investigation Activity, ALJ Johnson-Hines, and More from ACI’s ITC Conference This year’s ACI ITC Litigation and Enforcement Conference did not disappoint, delivering keynotes and panels on critical issues impacting the ITC. WIT was proud to sponsor the event once again and is pleased to share a few key takeaways.
Case Study- Technology Case Study: Wireless Communications Expert Needed for PTAB Proceedings A technology company petitioned for IPR proceedings to challenge the validity of two wireless communications patents, arguing that the patented methods were already established industry practices.
April 11, 2025 — Q&As Expert Witness Anxiety and Authenticity: A Q&A with DOAR Trial Consultant Dr. Roy Futterman How can expert witnesses connect with skeptical jurors? We asked a seasoned trial consultant from DOAR to provide strategies to help experts build credibility, manage stress, and deliver compelling testimony at trial.
April 11, 2025 — Case Study- Life Sciences Case Study: Pharmaceutical Formulation Expert Needed for Breach of Contract and Trade Secret Litigation A pharmaceutical developer filed suit against a CDMO, alleging breach of contract and trade secret misappropriation related to a sterile injectable chemotherapy formulation. WIT provided a pharmaceutical formulation expert with deep experience in injectable drugs and scale-up processes to assess whether the data shared under the agreement was sufficient for product replication.
February 18, 2025 — Q&As Rethinking Experience: Why New Expert Witnesses Deserve a Closer Look To explore the value of emerging testifying experts, we spoke with several members of the WIT team to gain insights on addressing client concerns, shifting perceptions, and how strategic preparation can turn fresh talent into indispensable litigation assets.
February 3, 2025 — Press Release WIT Legal Releases 2nd Annual Report on Trends in Hatch-Waxman Litigation The new report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue throughout 2024.
January 31, 2025 — Report 2024 in Review: Analyzing Hatch-Waxman Litigation Trends Our latest Hatch-Waxman report, 2024 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2024’s activities and trends in ANDA litigation.
January 13, 2025 — Q&As A Conversation with WIT’s Hatch-Waxman Practice Chair: Examining 2024 ANDA Litigation Activity Recently, we spoke to our Hatch-Waxman Practice Chair, Michael Crowe, to gain insights into Hatch-Waxman litigation trends in 2024. Here’s what he had to say about filings and possible trends in the year ahead.
December 18, 2024 — Report WIT Hatch-Waxman Report: Judge Michael Shipp Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp's activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings.
December 12, 2024 — Blog Expert Qualifications Under Revised FRE 702: A Look at Recent Cases The 2023 amendment to Federal Rule of Evidence (FRE) 702 has introduced stricter standards for expert testimony, challenging litigators to adapt to the evolving requirements. Let’s take a look at five recent cases to see how courts are putting these requirements into practice—insights that will prove particularly valuable for litigators planning their expert strategy.
December 4, 2024 — Case Study- Life Sciences Case Study: Medical Device Expert Needed for Cardiovascular Patent Dispute Before the PTAB The petitioner challenged the validity of several patents covering catheter-based delivery systems for heart valve replacement. The patent owner turned to WIT for an expert in cardiovascular medical devices and regulatory processes.
November 6, 2024 — Blog Perspectives on the Amendment to Rule 702 To better understand how the amendment is reshaping the way expert testimony is being handled, we contacted key stakeholders for their insights. From the perspectives of an attorney, expert liaison, and expert witness, these changes are prompting more thorough vetting and strategic planning in selecting experts for matters.
